Diabetes Mellitus, Diabetic Retinopathy (DR)
Conditions
Brief summary
The goal of this clinical trial is to determine whether there is an increase in participant uptake of diabetes mellitus (DM) and diabetic retinopathy (DR) services and improved quality of patient-centered diabetic care resulting from the use of automated voice message reminders to sensitize people with DM about the potential for sight loss alongside the provision of free reading glasses. The main questions it aims to answer are: 1. Will the proportion of patients completing their scheduled DR and DM appointments within 3 weeks of the scheduled date be significantly increased in the group receiving the automated voice messages containing both appointment reminders and messaging about the importance of visit and medication compliance in reducing the risk of vision loss, compared with participant messages which only remind them of their appointments? 2. What is the cost-effectiveness, measured as total intervention cost per additional patient complying with the suggested exam?
Interventions
OTHEREducation/information of risk
Participant will receive a message underscoring risk of vision loss from poorly controlled DM, and how this risk can be largely eliminated with excellent compliance with mediations and clinical visits.
OTHERFree eye glasses
Participants will receive a free pair of reading glass at their first appointment
Sponsors
District Diabetes Hospital, Dinajpur district of Bangladesh
Gausul Azam BNSB Eye Hospital, Dinajpur district of Bangladesh
Orbis
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosed with DM within the last 6 months * Over 30 years of age * Currently treated at the Dinajpur Diabetes Hospital * Possess a mobile phone to receive voice messages * Willingness to participate in the study, and ability to give informed consent
Exclusion criteria
* Other significant causes of vision loss * Medical conditions that could impair compliance with follow-up (such as stroke, dementia, etc.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of patients completing their diabetes or DR exam within 3 weeks of the scheduled date. | 3 weeks following scheduled exam date |
Secondary
| Measure | Time frame |
|---|---|
| Cost-effectiveness, measured as total intervention cost per additional patient adherence with the suggested exam. | Enrollment to 3 weeks following suggested exam date |
Countries
Bangladesh
Contacts
Primary ContactLutful Husain
Backup ContactNathan Congdon
Outcome results
None listed